Nicotinamide phosphoribosyltransferase, or nicotinamide phosphoribosyltransferase (NAMPT), is the primary rate-limiting enzyme in the NAD+ remediation production pathway, which is heavily dependent on AML cells. This evidence concerns the gene NAMPT and acute myeloid leukemia.